Enovix Corp Files 8-K Report

TL;DR

Enovix filed an 8-K, standard corporate update, no major news in this snippet.

AI Summary

On September 5, 2025, Enovix Corporation filed an 8-K report. The filing primarily concerns "Other Events" and does not detail specific transactions or financial figures within the provided text. It confirms Enovix Corporation's status as a Delaware corporation with its principal executive offices located at 3501 W. Warren Avenue, Fremont, California.

Why It Matters

This filing serves as an official notification to the SEC and the public about significant corporate events, though the specific nature of these events is not detailed in this excerpt.

Risk Assessment

Risk Level: low — The filing is a routine 8-K report and does not contain information that inherently increases risk.

Key Players & Entities

• Enovix Corporation (company) — Registrant
• 3501 W. Warren Avenue, Fremont, California (location) — Principal Executive Offices
• Rodgers Silicon Valley Acquisition Corp (company) — Former Company Name

FAQ

Key Financial Figures

• $0.0001 — ich registered Common Stock, par value $0.0001 per share ENVX The Nasdaq Global Select
• $8.75 — f Common Stock, at an exercise price of $8.75 per share ENVXW The Nasdaq Stock Marke
• $11.50 — s also resulted in an adjustment to the $11.50 exercise price of the private warrants
• $10.66 — approved an adjusted exercise price of $10.66 per Private Warrant. There are 5,500,00

Filing Documents

• envx-20250905.htm (8-K) — 34KB
• envx8-kxq3x90525exh991pr.htm (EX-99.1) — 16KB
• envx-20250905_g1.jpg (GRAPHIC) — 10KB
• image_0a.jpg (GRAPHIC) — 3KB
• 0001828318-25-000293.txt ( ) — 187KB
• envx-20250905.xsd (EX-101.SCH) — 2KB
• envx-20250905_lab.xml (EX-101.LAB) — 21KB
• envx-20250905_pre.xml (EX-101.PRE) — 12KB
• envx-20250905_htm.xml (XML) — 3KB

01 Other Events

Item 8.01 Other Events. Expiration of Public Warrants and Gross Proceeds On September 5, 2025, Enovix Corporation, a Delaware corporation (the "Company"), issued a press release relating to the expiration of warrants (the "Warrants") pursuant to the Warrant Agreement, dated as of July 21, 2025, between the Company and Computershare Trust Company N.A., as Warrant Agent, and the Company's calculation of the gross proceeds generated from Warrant exercises as of September 5, 2025. The foregoing description is only a summary and is qualified in its entirety by reference to the press release filed as Exhibit 99.1 to this Form 8-K and incorporated herein by reference. Adjustment to Private Warrant Exercise Price The distribution of the Warrants also resulted in an adjustment to the $11.50 exercise price of the private warrants (the "Private Warrants") previously issued by the Company and outstanding under the Warrant Agreement, dated as of July 13, 2021, between the Company and Computershare Trust Company N.A., as Warrant Agent (the "2021 Warrant Agreement"). In accordance with the 2021 Warrant Agreement, the Company's board of directors has approved an adjusted exercise price of $10.66 per Private Warrant. There are 5,500,000 Private Warrants currently outstanding, which may only be exercised on a cashless basis. Share Repurchase Program Update In connection with the management of its capital structure, as of September 5, 2025, the Company has repurchased 5,437,556 shares of its common stock in accordance with its previously-announced share repurchase program. The timing and amount of any further repurchases will be determined at the Company's discretion, and subject to the share repurchase program. For more information relating to the Company's share repurchase program, please refer to the materials filed by the Company with the SEC and available at https://www.sec.gov.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press Release dated September 5, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Enovix Corporation Date: September 5, 2025 By: /s/ Arthi Chakravarthy Arthi Chakravarthy Chief Legal Officer and Head of Corporate Development